The copper in GHK-Cu

GHK and GHK-Cu

GHK spells glycine-histidine-lysine. GHK-Cu is that tripeptide bound to copper. The skin-regeneration review describes the copper-binding complex and its involvement in tissue rebuilding. Copper contributes to processes that cross-link collagen and elastin, the proteins giving skin support and spring.

I wince when Cu disappears halfway through an argument. A paper about free GHK, a copper complex and a mixture containing GHK can be asking different chemical questions, even when a search result groups them together.

There is a lovely historical wrinkle: GHK was first isolated from human plasma in 1973 after work on protein synthesis in aged liver tissue. Its later life as a cosmetic ingredient makes that starting point easy to overlook. The review traces the plasma finding and later skin research.

Skin collagen measurements

A 2025 review of topical GHK reports increased procollagen synthesis in 70% of GHK-Cu-treated subjects, compared with 50% for vitamin C and 40% for retinoic acid. Procollagen is material used to make collagen; that endpoint says something specific about synthesis. It doesn't give a percentage of people visibly rejuvenated.

The skin barrier complicates the story. A laboratory study using human skin layers measured copper penetration and retention over 48 hours. This was excised skin, rather than a trial of visible wrinkle changes in living volunteers. The topical review discusses formulation research intended to improve passage through the skin. I think that practical obstacle deserves space beside the appealing cell biology.

GHK hair trial; GHK gene analysis

The hair-growth trial enrolled 45 men over six months. Its active preparation combined free GHK with 5-aminolevulinic acid. Both tested strengths increased hair counts more than placebo, and no adverse events were reported. Free GHK plus another ingredient is the experimental object here; assigning the whole result to GHK-Cu would change it.

A different strand of research examines gene expression, meaning how actively cells use their instructions. The 2018 review of gene data discusses repair and protective pathways using cell and database analyses. The much-repeated figure of roughly 4,000 genes overstates what its stated threshold directly supports. I'd trade that impressive gene count for broader experimental replication. Much of this broader work comes from one investigator and collaborators, leaving replication a live question.

GHK-Cu safety

Copper Tripeptide-1 is a legal cosmetic ingredient. GHK-Cu has no FDA-approved medical indication, and injectable or swallowed systemic formulations remain unapproved. Small topical studies and cosmetic use provide a different record from the missing human pharmacokinetic and safety data for systemic use. The topical review describes the evidence and formulation limitations.

Skin-product accounts describe firmness, softer fine lines and improved hydration; others describe redness, itching, dryness or breakouts. These anecdotes are personal impressions rather than clinical evidence. Reports involving injections have still less supporting human research.

Prolonged systemic copper exposure raises a theoretical accumulation concern, particularly with copper-handling conditions such as Wilson's disease; the research record has not established human copper toxicity from GHK-Cu. Strong acids and vitamin C can also destabilise the complex, a formulation issue discussed in the topical review. That tiny Cu suffix carries a remarkable chemical workload.